RxDoctor Payments Data

Linda Kalivas

Child & Adolescent Psychiatry · Scottsdale, AZNPI 1518000199

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.3% of the total across 370 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Corium, LLC at 24.2% of the total. Reporting peaked in 2023 at $3,777 and has fallen 61.6% since, to $1,451 in 2025. Among child & adolescent psychiatry clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,863in general payments, 2019–2025

Across 370 payments — averaging $34.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$3K
  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Tris Pharma Inc$1K
  • Ironshore Pharmaceuticals Inc.$867
  • plus $4K from 23 others

What the payments were for

  • Consulting fees$1,2009%
  • Travel & lodging$450%
  • Food & beverage$11,61590%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,863 in reported general payments places this provider in the 90th percentile of 80 child & adolescent psychiatry providers in Arizona.

See all child & adolescent psychiatry providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl11$1,847
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$1,549
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$1,462
Venlafaxine Hcl ErVenlafaxine Hcl32$1,203
Bupropion XlBupropion Hcl21$726
Fluoxetine Hcl11$203
Quetiapine Fumarate14$107
Alprazolam15$52
Clonazepam11$37

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →